glp 1 blood brain barrier The glucagon-like peptide (GLP) receptor as a therapeutic target in Parkinson's disease: mechanisms of action Does Tirzepatide Cross the Blood-Brain

Our recent review article is shedding light on how tumors outsmart treatment

Sturek, J

The study suggests that the second dose of the vaccine protected more than 90% of people from either being infected or having asymptomatic COVID-19 than around 50% of those who received only one dose

The development of MNMs may draw inspiration from current nano-platform technologies, and by endowing them with autonomous mobility capabilities, the development of MNMs may be accelerated

Clinicamente, ci si traduce in un ispessimento della pelle e in una migliore funzione di barriera , contrastando l'assottigliamento cutaneo tipico dell'invecchiamento